PubMed

Starting highly active antiretroviral therapy for HIV infection: is it WIHS to wait?

Schooley RT.

Ann Intern Med. 2004 Feb 17;140(4):305-6. No abstract available. PMID: 14970155 [PubMed - indexed for MEDLINE]Related articlesFree article

Summaries for patients. The relationship of pre- and post-treatment laboratory tests with outcomes for women starting treatment for HIV infection.

[No authors listed]

Ann Intern Med. 2004 Feb 17;140(4):I45. No abstract available. PMID: 14970171 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of maintaining highly active antiretroviral therapy on AIDS events among patients with late-stage HIV infection and inadequate response to therapy.

Gandhi T, Wei W, Amin K, Kazanjian P.

Clin Infect Dis. 2006 Mar 15;42(6):878-84. Epub 2006 Feb 8.PMID: 16477568 [PubMed - indexed for MEDLINE]Related articles

[Predictors of progression and death in patients with advanced HIV infection in the era of highly active antiretroviral therapy]

Reus S, Portilla J, Gimeno A, Sánchez-Payá J, García-Henarejos JA, Martínez-Madrid O, Usó J, Roca B, Galindo MJ, López-Aldeguer J.

Enferm Infecc Microbiol Clin. 2004 Mar;22(3):142-9. Spanish. PMID: 14987534 [PubMed - indexed for MEDLINE]Related articlesFree article

Adding IL-2 to anti-HIV drugs increases CD4+ cell counts without raising HIV levels.

[No authors listed]

AIDS Read. 2000 Sep;10(9):522-3. No abstract available. PMID: 11019440 [PubMed - indexed for MEDLINE]Related articles

Remission of disseminated infection caused by Encephalocytozoon intestinalis with highly active antiretroviral therapy.

Lafaurie M, Sarfati C, Menotti J, Molina JM.

AIDS. 2003 Mar 7;17(4):640-1. No abstract available. PMID: 12598791 [PubMed - indexed for MEDLINE]Related articles

Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.

Bonnet F, Thiébaut R, Chêne G, Neau D, Pellegrin JL, Mercié P, Beylot J, Dabis F, Salamon R, Morlat P; Groupe d'Epidemiologie Clinique du SIDA en Aquitaine (GECSA).

HIV Med. 2005 May;6(3):198-205.PMID: 15876287 [PubMed - indexed for MEDLINE]Related articles

Progression to AIDS and death in the era of HAART.

Hill A.

AIDS. 2006 Apr 24;20(7):1067-8. No abstract available. PMID: 16603862 [PubMed - indexed for MEDLINE]Related articles

[Decline in AIDS and death rates in the EuroSIDA study. An observational study]

Kirk O, Mocroft A, Lundgren JD; EuroSIDA-studiet.

Ugeskr Laeger. 2004 Jun 21;166(26-31):2572-6. Danish. No abstract available. PMID: 15285167 [PubMed - indexed for MEDLINE]Related articles

Discordant responses to HAART in HIV-1 patients: the need to focus on intervention.

De Maria A.

Expert Rev Anti Infect Ther. 2007 Aug;5(4):523-7. No abstract available. PMID: 17678414 [PubMed - indexed for MEDLINE]Related articles

Virologic and immunologic response to highly active antiretroviral therapy.

Jacobson LP, Phair JP, Yamashita TE.

Curr HIV/AIDS Rep. 2004 Jun;1(2):74-81. Review.PMID: 16091226 [PubMed - indexed for MEDLINE]Related articles

Normalized CD8+ but not CD4+ lymphocyte IL-2 expression is associated with early treatment with highly active antiretroviral therapy.

Akerele T, Galatowicz G, Bunce C, Calder V, Lynn WA, Lightman S.

Clin Immunol. 2006 Nov;121(2):191-7. Epub 2006 Sep 20.PMID: 16987710 [PubMed - indexed for MEDLINE]Related articles

Non-B HIV type 1 subtypes: replicative capacity and response to antiretroviral therapy.

Nicastri E, Sarmati L, d'Ettorre G, Parisi SG, Palmisano L, Montano M, Buonomini AR, Galluzzo C, Vullo V, Concia E, Vella S, Andreoni M.

AIDS Res Hum Retroviruses. 2004 Aug;20(8):816-8. No abstract available. PMID: 15320985 [PubMed - indexed for MEDLINE]Related articles

Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.

Viani RM, Araneta MR, Deville JG, Spector SA.

Clin Infect Dis. 2004 Sep 1;39(5):725-31. Epub 2004 Aug 16.PMID: 15356789 [PubMed - indexed for MEDLINE]Related articles

A one-year clinical trial using didanosine, stavudine and nevirapine for highly active antiretroviral therapy.

Zhou HY, Zheng YH, Zhang CY, Ding PP, Zou W.

Chin Med J (Engl). 2005 Apr 5;118(7):609-11. No abstract available. PMID: 15820096 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count.

García F, de Lazzari E, Plana M, Castro P, Mestre G, Nomdedeu M, Fumero E, Martínez E, Mallolas J, Blanco JL, Miró JM, Pumarola T, Gallart T, Gatell JM.

J Acquir Immune Defic Syndr. 2004 Jun 1;36(2):702-13.PMID: 15167289 [PubMed - indexed for MEDLINE]Related articles

Salvaging HAART.

Laurence J.

AIDS Read. 1999 Jul;9(4):234-5. No abstract available. PMID: 12737111 [PubMed - indexed for MEDLINE]Related articles

Immunologic response to antiretroviral therapy in hepatitis C virus-coinfected adults in a population-based HIV/AIDS treatment program.

Braitstein P, Zala C, Yip B, Brinkhof MW, Moore D, Hogg RS, Montaner JS.

J Infect Dis. 2006 Jan 15;193(2):259-68. Epub 2005 Dec 7.PMID: 16362890 [PubMed - indexed for MEDLINE]Related articles

[Antiviral therapy: when to begin, which goals should be set, what must be kept in mind? Tips for nonspecialists]

Jablonowski H.

MMW Fortschr Med. 2005 Apr 25;147 Spec No 1:10-1. German. No abstract available. PMID: 16385862 [PubMed - indexed for MEDLINE]Related articles

Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial.

INITIO Trial International Co-ordinating Committee, Yeni P, Cooper DA, Aboulker JP, Babiker AG, Carey D, Darbyshire JH, Floridia M, Girard PM, Goodall RL, Hooker MH, Mijch A, Meiffredy V, Salzberger B.

Lancet. 2006 Jul 22;368(9532):287-98.PMID: 16860698 [PubMed - indexed for MEDLINE]Related articles